Bexmarilimab
FP2CLI004
Phase 2 small_molecule active
Quick answer
Bexmarilimab for Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active